Venus Remedies Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1,169 million compared to INR 1,243.4 million a year ago. Revenue was INR 1,207.1 million compared to INR 1,255.6 million a year ago. Net income was INR 32.9 million compared to INR 56.5 million a year ago. Basic earnings per share from continuing operations was INR 2.46 compared to INR 4.22 a year ago. Diluted earnings per share from continuing operations was INR 2.46 compared to INR 4.22 a year ago.
For the nine months, sales was INR 3,998.7 million compared to INR 4,567.2 million a year ago. Revenue was INR 4,069.1 million compared to INR 4,627.8 million a year ago. Net income was INR 155.1 million compared to INR 404.9 million a year ago. Basic earnings per share from continuing operations was INR 11.6 compared to INR 30.68 a year ago. Diluted earnings per share from continuing operations was INR 11.6 compared to INR 30.68 a year ago.